Modification of laboratory results by partial treatment of bacterial meningitis.
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D001407:Bacillus / Q000302:isolation & purification; D001431:Bacteriological Techniques; D001772:Blood Cell Count; D002555:Cerebrospinal Fluid / Q000382:microbiology; D002556:Cerebrospinal Fluid Proteins / Q000032:analysis; D005947:Glucose / Q000134:cerebrospinal fluid; D006193:Haemophilus influenzae / Q000302:isolation & purification; D006801:Humans; D008089:Listeria monocytogenes / Q000302:isolation & purification; D008581:Meningitis / Q000134:cerebrospinal fluid / Q000175:diagnosis* / Q000188:drug therapy / Q000382:microbiology; D009345:Neisseria meningitidis / Q000302:isolation & purification; D011549:Pseudomonas / Q000302:isolation & purification; D013210:Staphylococcus / Q000302:isolation & purification; D013291:Streptococcus / Q000302:isolation & purification; D013296:Streptococcus pneumoniae / Q000302:isolation & purification
D000900:Anti-Bacterial Agents; D002556:Cerebrospinal Fluid Proteins; D005947:Glucose